Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
MARBOFLOXACIN
Krka, d.d., Novo mesto
QJ01MA93
MARBOFLOXACIN
100 Mg/Ml
Solution for Injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle, Pigs
marbofloxacin
Antibacterial
Authorised
2012-08-17
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Ubiflox 100 mg/ml solution for injection for cattle and pigs (sows) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of solution for injection contains: ACTIVE SUBSTANCE: Marbofloxacin 100 mg EXCIPIENTS: Disodium edetate 0.10 mg Monothioglycerol 1 mg Metacresol 2 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. Clear, greenish yellow to brownish yellow solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and pigs (sows). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES CATTLE Treatment of respiratory infections caused by sensitive strains of_ Pasteurella multocida_,_ Mannheimia haemolytica,_ _Mycoplasma bovis_ and_ Histophilus somni_. Treatment of acute mastitis caused by_ Escherichia coli_ strains sensitive to marbofloxacin during the lactation period. SOWS Treatment of Metritis Mastitis Agalactia Syndrome (postpartum dysgalactiae syndrome, PDS) caused by bacterial strains sensitive to marbofloxacin. 4.3 CONTRAINDICATIONS Do not use in animals with known hypersensitivity to the active substance or to any of the excipients. Do not use in cases where the pathogen involved is resistant to other fluoroquinolones (cross resistance). 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _1_ _5_ _/_ _0_ _7_ _/_ _2_ _0_ _1_ _6_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _2_ _0_ _5_ _9_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _ Read the complete document